Jersey City, New Jersey, Nov. 18, 2022 (GLOBE NEWSWIRE) -- Verified Market Research recently published a report, “Viral Vector Manufacturing Market” By Type (Retroviral Vectors, Adenoviral Vectors, Adeno-Associated Viral Vectors, and Others), By Application (Gene Therapy and Vaccinology Development), By Geographic Scope And Forecast.
As per the deep research carried out by Verified Market Research, the global Viral Vector Manufacturing Market size was valued at USD 424.02 Million in 2020 and is projected to reach USD 1,733.42 Million by 2028, growing at a CAGR of 19.1% from 2021 to 2028.
Download PDF Brochure: https://www.verifiedmarketresearch.com/download-sample/?rid=27621
Browse in-depth TOC on “Viral Vector Manufacturing Market”
202 - Pages
126 – Tables
37 – Figures
Global Viral Vector Manufacturing Market Overview
Viruses are infectious organisms that can only exist if they are housed inside a living cell. In many genetic, vaccination, and molecular biology applications, viral vectors are created to deliver genetic materials into the target cells. Additionally, viral vectors are used to explore a variety of therapeutic fields. Utilizing viruses and cell cultures from animals or insects, viral vectors are produced.
The growing global burden of cancer, infectious diseases, and genetic disorders is increasing in several countries, acting as the market's primary driver. The prevalence of genetic disorders, cancer, and infectious diseases is rising, as is the number of viral vector clinical trials and the availability of funding for the development of gene therapies. The viral vector manufacturing market is expanding significantly due to an increase in the availability of products based on gene therapy.
Key Players
The major players in the market are Novasep, Brammer Bio, Lonza, Cobra Biologics, Oxford Biomedica, Finvector Vision Therapies, Merck KGaA, Spark Therapeutics, uniQure, and Merck.
Verified Market Research has segmented the Global Viral Vector Manufacturing Market On the basis of Type, Application, and Geography.
- Viral Vector Manufacturing Market, By Type
- Adeno-Associated Viral Vectors
- Retroviral Vectors
- Adenoviral Vectors
- Others
- Viral Vector Manufacturing Market, By Application
- Gene Therapy
- Vaccinology Development
- Viral Vector Manufacturing Market, By Geography
- North America
- U.S
- Canada
- Mexico
- Europe
- Germany
- France
- U.K
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- Rest of Asia Pacific
- ROW
- Middle East & Africa
- Latin America
- North America
Browse Related Reports:
Recombinant Vaccines Market By Type (Subunit Recombinant Vaccines, Attenuated Recombinant Vaccines, Vector Recombinant Vaccines), By Disease (Hepatitis B, Sexually Transmitted Diseases, Cancer), By Geography, And Forecast
CRISPR and Cas Genes Market By Therapeutic (Oncology, Inflammatory/Autoimmune), By Product (DNA-Free Cas, Vector-Based Cas), By Application (Genome Engineering, Functional Genomics), By End-User (Pharmaceutical And Biotechnology Companies, Contract Research Organizations), By Geography, And Forecast
Recombinant DNA Technology Market By Product (Medical, Non-Medical), By Component (Expression System, Cloning Vector), By Application (Food & Agriculture, Health & Diseases, Environment), By Geography, And Forecast
cDNA Clone Vector Market By Type (Rat, Cat, Horse, Dog, Monkey, Human, Others), By Application (BioScience Companies, Hospital, and Clinics, Universities and Institutions, Others), By Geography, And Forecast
Top 5 Infection Control Companies severance the contamination internationally
Visualize Viral Vector Manufacturing Market using Verified Market Intelligence -:
Verified Market Intelligence is our BI-enabled platform for narrative storytelling in this market. VMI offers in-depth forecasted trends and accurate Insights on over 20,000+ emerging & niche markets, helping you make critical revenue-impacting decisions for a bright future.
VMI provides a holistic overview and global competitive landscape with respect to Region, Country, Segment, and Key players of your market. Present your Market Report & findings with an inbuilt presentation feature saving over 70% of your time and resources for Investor, Sales & Marketing, R&D, and Product Development pitches. VMI enables data delivery In Excel and Interactive PDF formats with over 15+ Key Market Indicators for your market.
About Us
Verified Market Research is a leading Global Research and Consulting firm servicing over 5000+ customers. Verified Market Research provides advanced analytical research solutions while offering information-enriched research studies. We offer insight into strategic and growth analyses, Data necessary to achieve corporate goals, and critical revenue decisions.
Our 250 Analysts and SMEs offer a high level of expertise in data collection and governance and use industrial techniques to collect and analyze data on more than 15,000 high-impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise, and years of collective experience to produce informative and accurate research.
We study 14+ categories from Semiconductors & Electronics, Chemicals, Advanced Materials, Aerospace & Defense, Energy & Power, Healthcare, Pharmaceuticals, Automotive & Transportation, Information & Communication Technology, Software & Services, Information Security, Mining, Minerals & Metals, Building & Construction, Agriculture industry and Medical Devices from over 100 countries.
